Extreme Investor Network

BofA predicts that this uncommon muscle disease drug could see more than 50% increase in sales

May 5, 2024

This rare muscle disease play can rally more than 50%, BofA says

Welcome to Extreme Investor Network, where we provide you with cutting-edge insights into the world of investing. Today, we’re diving into the exciting world of biotech with a close look at Avidity Biosciences stock. According … Read more

Trial shows Altimmune weight loss drug significantly reduces muscle loss

March 27, 2024

Altimmune weight loss drug minimized muscle mass loss in trial

Altimmune’s Weight Loss Drug Shows Promise in Preserving Muscle Mass Altimmune announced on Wednesday that its experimental weight loss drug not only helped patients shed weight but also minimized the loss of muscle mass in … Read more